These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 22724262)

  • 21. Questioning the benefits of statins.
    Mazowita G
    CMAJ; 2005 Nov; 173(10):1210; author reply 1210. PubMed ID: 16275979
    [No Abstract]   [Full Text] [Related]  

  • 22. Dyslipidemia and the risk of end stage renal disease.
    Haydar AA; Goldsmith DJ
    J Med Liban; 2004; 52(3):156-9. PubMed ID: 16432973
    [No Abstract]   [Full Text] [Related]  

  • 23. Pitavastatin for the treatment of primary hyperlipidemia and mixed dyslipidemia.
    Gotto AM; Moon J
    Expert Rev Cardiovasc Ther; 2010 Aug; 8(8):1079-90. PubMed ID: 20670185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dyslipidaemia, statins and rheumatoid arthritis.
    Nurmohamed MT; Dijkmans BA
    Ann Rheum Dis; 2009 Apr; 68(4):453-5. PubMed ID: 19286903
    [No Abstract]   [Full Text] [Related]  

  • 25. High-density lipoproteins may offer a more promising route to statin therapy.
    Coaker H
    Future Cardiol; 2014 Mar; 10(2):164. PubMed ID: 24883441
    [No Abstract]   [Full Text] [Related]  

  • 26. An identification of the novel combination therapy for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cells.
    Moriguchi H; Chung RT; Sato C
    Hepatology; 2010 Jan; 51(1):351-2. PubMed ID: 20034040
    [No Abstract]   [Full Text] [Related]  

  • 27. Cholesterol and peripheral vascular disease: a neglected topic?
    Atar D; Jørgensen JJ
    Scand Cardiovasc J; 2007 Jun; 41(3):136-7. PubMed ID: 17487760
    [No Abstract]   [Full Text] [Related]  

  • 28. Pitavastatin Nissan/Kowa Yakuhin/Novartis/Sankyo.
    Flores NA
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1334-41. PubMed ID: 12498010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy of pitavastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in patients with hyperlipidemia. Dose-finding study using the double-blind, three-group parallel comparison.
    Saito Y; Yamada N; Teramoto T; Itakura H; Hata Y; Nakaya N; Mabuchi H; Tushima M; Sasaki J; Goto Y; Ogawa N
    Arzneimittelforschung; 2002; 52(4):251-5. PubMed ID: 12040967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expanding role of the HMG-CoA reductase inhibitor, the most widely prescribed drug in the world.
    Futterman LG; Lemberg L
    Am J Crit Care; 2005 Nov; 14(6):555-8. PubMed ID: 16249593
    [No Abstract]   [Full Text] [Related]  

  • 31. Viewpoint: Terje R. Pedersen, MD, PhD. Interview by Robert Short.
    Pedersen TR
    Circulation; 2007 Mar; 115(12):f51-2. PubMed ID: 17393574
    [No Abstract]   [Full Text] [Related]  

  • 32. The potential role of HDL- and LDL-cholesterol modulation in atheromatous plaque development.
    Chapman MJ
    Curr Med Res Opin; 2005; 21 Suppl 6():S17-22. PubMed ID: 16138937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs for lipids.
    Treat Guidel Med Lett; 2011 Mar; 9(103):13-20. PubMed ID: 21350395
    [No Abstract]   [Full Text] [Related]  

  • 34. Re: Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.
    Yoshii Y; Ikeda K; Iwamoto K; Kawase Y; Iwasaki Y
    Neurology; 2009 Mar; 72(10):944; author reply 944-5. PubMed ID: 19273834
    [No Abstract]   [Full Text] [Related]  

  • 35. A case report of a diabetic woman with very low HDL cholesterol.
    Chaychi L; Kinlaw WB; Asztalos BF; Schaefer EJ
    J Clin Lipidol; 2010; 4(2):133-5. PubMed ID: 21122641
    [No Abstract]   [Full Text] [Related]  

  • 36. Prostaglandin E1 dose-dependently promotes stability of atherosclerotic plaque in a rabbit model.
    Bai W; Zheng X; Zhou L; Li H
    Can J Physiol Pharmacol; 2012 Feb; 90(2):131-9. PubMed ID: 22309388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients.
    Ogata N; Fujimori S; Oka Y; Kaneko K
    Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):321-4. PubMed ID: 20544514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LDL-Cholesterol is the King.
    Goumas GS
    Angiology; 2009; 60(3):387-8. PubMed ID: 19497926
    [No Abstract]   [Full Text] [Related]  

  • 39. A randomized, open-label study to evaluate the efficacy and safety of pitavastatin compared with simvastatin in Korean patients with hypercholesterolemia.
    Park S; Kang HJ; Rim SJ; Ha JW; Oh BH; Chung N; Cho SY
    Clin Ther; 2005 Jul; 27(7):1074-82. PubMed ID: 16154486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescribe exercise for men with dyslipidaemia.
    BMJ; 2012 Dec; 345():e8209. PubMed ID: 23207505
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.